Maturity-onset diabetes of the young (MODY): an update
The DOI matches its Crossref record; 114 of the 118 references it cites were found in a registry or an index.
Abstract
Maturity-onset diabetes of the young (MODY) is a group of monogenic disorders characterized by autosomal dominantly inherited non-insulin dependent form of diabetes classically presenting in adolescence or young adults before the age of 25 years. MODY is a rare cause of diabetes (1% of all cases) and is frequently misdiagnosed as Type 1 diabetes (T1DM) or Type 2 diabetes (T2DM). A precise molecular diagnosis is essential because it leads to optimal treatment of the patients and allows early diagnosis for their asymptomatic family members. Mutations in the glucokinase (GCK) (MODY 2) and hepatocyte nuclear factor (HNF)1A/4A (MODY 3 and MODY 1) genes are the most common causes of MODY. GCK mutations cause a mild, asymptomatic, and stable fasting hyperglycemia usually requiring no specific treatment. However, mutations in the HNF1A and HNF4A cause a progressive pancreatic β-cell dysfunction and hyperglycemia that can result in microvascular complications. Sulfonylureas are effective in these patients by acting on adenosine triphosphate (ATP)-sensitive potassium channels, although insulin therapy may be required later in life. Mutations in the HNF1B (MODY 5) is associated with pancreatic agenesis, renal abnormalities, genital tract malformations, and liver dysfunction. Compared to MODY 1, 2, 3, and 5, the remaining subtypes of MODY have a much lower prevalence. In this review, we summarize the main clinical and laboratory characteristics of the common and rarer causes of MODY.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risks of microvascular and macrovascular complications with HNF1A-MODY and HNF4AMODY are similar to those observed in people with type 1 and type 2 diabetes (175,176).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [176]
Citations
Cites
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 2×
“The decrease in GCK activity in pancreatic β-cells caused by GCK mutations lead to decreased glucose phosphorylation and glucose sensitivity in β-cells, and a shift in the dose-response relationship between plasma glucose concentrations and insulin secretion to the right (21).”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
Malecki, M. T., Jhala, U. S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J. H., Montminy, M., & Krolewski, A. S. (1999) · Nature Genetics · doi:10.1038/15500 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607 · cited 4×
“A correct diagnosis and differentiating MODY from T1DM and T2DM are important when deciding on a patient’s treatment and determining his or her prognosis, as well as detecting at-risk family members (31, 82, 83).”
BackgroundInfluentialOsbak, K. K., Colclough, K., Saint-Martin, C., Beer, N. L., Bellanné-Chantelot, C., Ellard, S., & Gloyn, A. L. (2009) · Human Mutation · doi:10.1002/humu.21110 · Cited by 485
Tattersall, R. B., Fajans, S. S., & Arbor, A. (1975) · Diabetes · doi:10.2337/diab.24.1.44 · Cited by 475
Pearson, E. R., Boj, S. F., Steele, A. M., Barrett, T., Stals, K., Shield, J. P., Ellard, S., Ferrer, J., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 427
Stoffel, M., & Duncan, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13209 · Cited by 406
Research works printed but not linked: 93
- McDonald, 2011, High - sensitivity CRP discriminates from other subtypes of diabetes, Diabetes Care, 10.2337/dc11-0323 · DOI · Paper page
- Spyer, 2001, AT KM Influence of maternal and fetal glucokinase mutations in gestational diabetes, Am J Obstet Gynecol, 185
- Hattersley, 1998, AT Maturity - onset diabetes of the young : clinical heterogeneity explained by genetic heterogeneity, Med, 15, 15
- Chakera, 2012, Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment, Diabetes Care, 10.2337/dc12-0151 · DOI
- Borowiec, 2009, Mutations at the BLK locus linked to maturity onset diabetes of the young and beta - cell dysfunction, Proc Natl Acad Sci USA, 106
- Fajans, 1993, MB Administration of sulfonylureas can increase glucose - induced insulin secretion for decades in patients with maturity - onset diabetes of the young, Diabetes Care, 16, 10.2337/diacare.16.9.1254 · DOI · Paper page
- Colom, 2010, Maturity onset diabetes of the young and pregnancy, Pract Res Clin Endocrinol Metab, 24, 605, 10.1016/j.beem.2010.05.008 · DOI
- Cerf, 2006, ME factors regulating beta function, Transcription cell Eur J Endocrinol, 155
- Schober, 2009, Phenotypical aspects of maturity - onset diabetes of the young diabetes in comparison with Type diabetes mellitus DM in children and adolescents : experience from a large multicentre database, Med, 26, 466
- Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
- Molven, 2011, PR Role of molecular genetics in transforming diagnosis of diabetes mellitus, Expert Rev Mol Diagn, 11, 313, 10.1586/erm.10.123 · DOI · Paper page
- Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
- Massa, 2001, High prevalence of glucokinase mutations in Italian children with MODY Influence on glucose tolerance first - phase insulin response insulin sensitivity and BMI, Diabetologia, 898
- Pearson, 2004, Contrasting diabetes phenotypes associated with hepatocyte nuclear factor alpha and beta mutations, Diabetes Care, 27, 1, 10.2337/diacare.27.5.1102 · DOI · Paper page
- Owen, 2002, AT Heterogeneity in young adult onset diabetes : aetiology alters clinical characteristics, Med, 19, 758
- Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
- Chen, 2010, Systematic review of anomalies in renal cysts and diabetes syndrome / maturity onset diabetes of the young type, Med Engl, 123
- Urbanova, 2013, Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity - onset diabetes of the young ? The case of autoimmunity - associated destruction of pancreatic beta - cells in a family of HNF MODY subjects, Int Arch Allergy, 1
- Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
- Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
- Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
- Pontoglio, 2000, alpha controls renal glucose reabsorption in mouse and man, EMBO Rep, 1
- Osbak, 2009, Update on mutations in glucokinase which cause maturity - onset diabetes of the young permanent neonatal diabetes and hyperinsulinemic hypoglycemia, Hum Mutat, 30, 10.1002/humu.21110 · DOI · Paper page
- Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
- Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
- Naylor, 2011, Who should have genetic testing for maturity - onset diabetes of the young, Clin Endocrinol, 422, 10.1111/j.1365-2265.2011.04049.x · DOI
- Borg, 2002, Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune Type diabetes in children older than yr of age, Pediatr Diabetes, 1
- Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
- Plengvidhya, 2007, mutations in Thais with maturity onset diabetes of the young, J Clin Endocrinol Metab, 2821, 10.1210/jc.2006-1927 · DOI · Paper page
- Fajans, 2010, and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the mutation Pro fsX, Obesity Transl Res, 63, 1
- Feigerlova, 2006, Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents, Eur J Pediatr, 165
- Kropff, 2011, Prevalence of monogenic diabetes in young adults : a community - based cross - sectional study in Oxfordshire UK, Diabetologia, 10.1007/s00125-011-2090-z · DOI
- Vaxillaire, 2012, The lessons of early - onset monogenic diabetes for the understanding of diabetes pathogenesis, Pract Res Clin Endocrinol Metab, 26, 171, 10.1016/j.beem.2011.12.001 · DOI
- Pearson, 2003, Genetic cause of hyperglycaemia and response to treatment in diabetes, Lancet, 362
- Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
- Tattersall, 1975, SS difference between the inheritance of classical juvenile - onset and maturity - onset type diabetes of young people, Diabetes, 24
- Raile, 2011, caused by insulin gene INS deletion clinical characteristics of homozygous and heterozygous individuals, Diabetes Eur J Endocrinol, 165
- McDonald, 2011, Islet autoantibodies can discriminate maturity - onset diabetes of the young from Type diabetes, Med, 28, 1
- Frayling, 1997, Mutations in the hepatocyte nuclear factor - alpha gene are a common cause of maturity - onset diabetes of the young in the, Diabetes, 1
- Pearson, 2007, and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the gene, PLoS Med, 10.1371/journal.pmed.0040118 · DOI · Paper page
- Pearson, 2005, Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor alpha mutations in a large European collection, Diabetologia, 4
- McDonald, 2013, Maturity onset diabetes of the young identification diagnosis, Ann Clin Biochem, 15, 403, 10.1177/0004563213483458 · DOI · Paper page
- MODY, 1995, Ledermann HM Maturity - onset diabetes of the young at least ten times more common in Europe than previously assumed, Diabetologia
- Harries, 2006, AT of the TCF gene encoding hepatocyte nuclear factor - alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes, Hum Mol Genet, 15, 1, 10.1093/hmg/ddl147 · DOI · Paper page
- Tattersall, 1974, Mild familial diabetes with dominant inheritance, J Med, 339
- Schwitzgebel, 2003, Agenesis of human pancreas due to decreased half - life of insulin promoter factor, J Clin Endocrinol Metab, 1
- Sera, 2000, Kawasaki Identification and functional analysis of mutations in the hepatocyte nuclear factor - alpha gene in anti - islet autoantibody - negative Japanese patients with Type diabetes, J Clin Endocrinol Metab, 1
- Bingham, 2001, Mutations in the hepatocyte nuclear factor beta gene are associated with familial hypoplastic glomerulocystic kidney disease, Am J Hum Genet, 24, 1
- Stride, 2002, The genetic abnormality in the beta cell determines the response to an oral glucose load, Diabetologia, 427, 10.1007/s00125-001-0770-9 · DOI · Paper page
- Lambert, 2003, Identifying hepatic nuclear factor alpha mutations in children and young adults with a clinical diagnosis of Type diabetes, Diabetes Care, 26, 1, 10.2337/diacare.26.2.333 · DOI · Paper page
- Edghill, 2006, AT Mutations in hepatocyte nuclear factor beta and their related phenotypes, J Med Genet, 1
- Bowden, 2008, Triple diabetes : coexistence of Type diabetes mellitus and a novel mutation in the gene responsible for MODY in an overweight adolescent, Pediatr Diabetes, 1
- Tuomi, 2006, Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity - onset diabetes of the young type, Diabetes Care, 29, 189, 10.2337/diacare.29.02.06.dc05-1314 · DOI · Paper page
- Habener, 2005, transcriptional regulation in pancreatic development, Endocrinology, 146
- Leslie, 1999, GAD in Type insulin dependent diabetes, Diabetologia, 42, 10.1007/s001250051105 · DOI · Paper page
- Cuesta, 2010, Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene, Diabetes Care, 290, 10.2337/dc09-0681 · DOI
- Shepherd, 2009, AT genetic diagnosis of diabetes alters treatment and improves glycaemic control in the majority of insulin - treated patients, Med, 26, 1
- Velho, 1997, Identification of new glucokinase mutations and description of the clinical profile of families, Diabetologia, 14, 217, 10.1007/s001250050666 · DOI · Paper page
- Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
- Steele, 2013, Use of in the identification of patients with hyperglycaemia caused by a glucokinase mutation : observational case control studies One, AM, 1
- Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
- Boesgaard, 2010, Further evidence that mutations in INS can be a rare cause of maturity - onset diabetes of the young, BMC Med Genet, 11
- Besser, 2011, RE Urinary - peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor alpha hepatocyte nuclear factor alpha maturity - onset diabetes of the young from long - duration Type diabetes, Diabetes Care, 1
- Colclough, 2013, Mutations in the genes encoding the transcription factors hepatocyte nuclear factor alpha alpha in maturity - onset diabetes of the young and hyperinsulinemic hypoglycemia, Hum Mutat, 1
- Molven, 2008, Mutations in the insulin gene can cause MODY and autoantibody - negative Type diabetes, Diabetes, 1
- Fajans, 2001, SS GI Molecular mechanisms and clinical pathophysiology of maturity - onset diabetes of the young, New Engl J Med, 345
- Edghill, 2006, Hepatocyte nuclear factor beta mutations cause neonatal diabetes and intrauterine growth retardation : support for a critical role of HNF beta in human pancreatic development, Med, 23, 1
- Ulinski, 2006, Renal phenotypes related to hepatocyte nuclear factor beta mutations in a pediatric cohort, J Am Soc Nephrol, 17, 497, 10.1681/asn.2005101040 · DOI · Paper page
- Galan, 2011, Differential effects of HNF alpha mutations associated with familial young - onset diabetes on target gene regulation, Mol Med, 17, 1, 10.2119/molmed.2010.00097 · DOI · Paper page
- Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
- Rubio, 2010, Homozygous mutations in are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities, Diabetes, 31, 1
- Neve, 2005, Role of transcription factor and its diabetes - associated gene variants in pancreatic beta cell function, Proc Natl Acad Sci USA, 11, 4807, 10.1073/pnas.0409177102 · DOI · Paper page
- Owen, 2010, Assessment of high - sensitivity reactive protein levels as diagnostic discriminator of maturity - onset diabetes of the young due to mutations, Diabetes Care, 24, 1
- Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
- Lehto, 1999, Mutation in the HNF alpha gene affects insulin secretion and triglyceride metabolism, Diabetes, 5, 423, 10.2337/diabetes.48.2.423 · DOI
- Raeder, 2006, PI IS Mas Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction, Nat Genet, 38
- Stride, 2014, Cross - sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia, Diabetologia, 57, 54, 10.1007/s00125-013-3075-x · DOI · Paper page
- Owen, 2003, AT Adolescent onset Type diabetes in a non - obese Caucasian patient with an unbalanced translocation, Med, 20, 483
- Owen, 2011, Thanabalasingham Diagnosis and management of maturity onset diabetes of the young, Brit Med J, 343
- Stoffel, 1997, The maturity - onset diabetes of the young transcription factor alpha regulates expression of genes required for glucose transport and metabolism, Proc Natl Acad Sci USA, 14, 1
- Fajans, 2011, GI genetics pathophysiology clinical decision making, history Diabetes Care, 10.2337/dc11-0035 · DOI · Paper page
- Meur, 2010, Insulin gene mutations resulting in early - onset diabetes : marked differences in clinical presentation metabolic status and pathogenic effect through endoplasmic reticulum retention, Diabetes, 59
- Pihoker, 2013, Prevalence characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in glucokinase : results from the SEARCH for Diabetes in Youth, J Clin Endocrinol Metab, 1
- Horikawa, 1997, Mutation in hepatocyte nuclear factor beta gene associated with, Nat Genet, 17, 384, 10.1038/ng1297-384 · DOI · Paper page
- Martin, 2008, Long - term follow - up of oral glucose tolerance test - derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations, Diabetes Care, 31, 10.2337/dc07-2017 · DOI
- Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young - onset diabetes, Diabetologia, 10.1007/s00125-011-2418-8 · DOI · Paper page
- Docena, 2014, KM novel mutation and the utility of glucagon - like peptide receptor agonist therapy, Endocr Pract, 20, 1, 10.4158/ep13254.or · DOI
- Moller, 1998, Mutations in the hepatocyte nuclear factor - alpha gene in Caucasian families originally classified as having Type I diabetes, AM Diabetologia, 31, 1
- Slingerland, 2006, AS diabetes in children and young adults : challenges for researcher clinician patient, Rev, 171
- Dukes, 1998, ID Defective pancreatic beta - cell glycolytic signaling in hepatocyte nuclear factor alpha - deficient mice, J Biol Chem, 1
- Steele, 2010, AT Increased all - cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the gene, AM Med, 27, 1
- Igarashi, 2005, Roles of beta in kidney development and congenital cystic diseases, Kidney Int, 1
- Gonsorcikova, 2008, Autosomal inheritance of diabetes in two families characterized by obesity and a novel mutation in, Pediatr Diabetes, 241
Cited by
Items 101–200 of 246
Liu, J., Yang, A., Lei, G., Yu, M., Peng, Y., & Le, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1059641 · Cited by 6
The challenges of diagnosing diabetes in childhood
Pucci, M., Benati, M., Cascio, C. L., Montagnana, M., & Lippi, G. (2020) · Diagnosis · doi:10.1515/dx-2020-0036 · Cited by 5
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?
Abdul‐Ghani, M. A., & DeFronzo, R. A. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1967319 · Cited by 5
A zebrafish model system for drug screening in diabetes
Mathews, B. (2019) · University Library of Skövde (University of Skövde) · Cited by 5
Ruiz-Urbaez, R., Villagómez-Estrada, M. V., Reyes-Silva, C. A., Lopez, D. P. Q., Males, D., Salazar-Vega, J., & Gea–Izquierdo, E. (2024) · Medicina · doi:10.3390/medicina60050830 · Cited by 5
Rydosz, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99887-1.00001-7 · Cited by 4
MODY2 diagnostic issues in adults
Кононенко, И. В., Glibka, A. A., Zubkova, N. V., Mayorov, A. Y., Tiulpakov, A. N., & Schmidt, O. (2019) · Diabetes Mellitus · doi:10.14341/dm10063 · Cited by 4
Focusing on Rare Variants Related to Maturity‐Onset Diabetes of the Young in Children
Ding, Y., Zhang, Q., Gao, S., Li, J., Chang, G., Wang, Y., Wang, L., Li, X., Chen, Y., Yao, R., et al. (2025) · Pediatric Diabetes · doi:10.1155/pedi/8155443 · Cited by 4
Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population
Relan, S., Alarcon, G., Guffey, D., Minard, C. G., Fang, M. E., Timmons, K., Sonabend, R., Tosur, M., REDONDO, M. J., & Posey, J. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf360 · Cited by 4
Pérez-López, P., Bahillo-Curieses, P., Fernández-Velasco, P., Martínez, R., Delgado, E., Ortolá, A., de Luis, D. A., & Díaz-Soto, G. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.03.006 · Cited by 4
Winter, W. E., Pittman, D. L., Devaraj, S., Li, D., & Harris, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00008-x · Cited by 4
Diagnosis and Management of Monogenic Diabetes in Pregnancy
Jones, O., Chakera, A. J., & Edensor, S. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220514153021 · Cited by 4
Diagnosis and Treatment of Monogenic Forms of Diabetes Mellitus: Focus on Mody-Diabetes
Айтбаев, К. А., Murkamilov, I. T., Абдилалимовна, М. Ж., Fomin, V. V., Kudaibergenova, I., & Yusupov, F. A. (2022) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2022-12-6-430-437 · Cited by 4
Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
Dabi, Y. T., & Degechisa, S. T. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s366967 · Cited by 4
Zhou, Y., Sun, Y., Xu, C., Liu, F., Gao, Y., Liu, C., Qiao, Y., Yang, J., & Li, G. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13388 · Cited by 4
Bawatneh, A., Darwish, A., Eideh, H., & Darwish, H. M. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2023.1292073 · Cited by 4
Bonetti, S., Zusi, C., Rinaldi, E., Boselli, M., Csermely, A., Malerba, G., Trabetti, E., Bonora, E., Bonadonna, R. C., & Trombetta, M. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101323 · Cited by 4
Hermayanti, D., & Nursiloningrum, E. (2018) · Saintika Medika · doi:10.22219/sm.vol14.smumm2.7162 · Cited by 4
iPSC for modeling of metabolic and neurodegenerative disorders
Valadez-Barba, V., Cota-Coronado, A., Barragán-Álvarez, C. P., Padilla‐Camberos, E., & Diaz-Martinez, N. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00007-2 · Cited by 3
Kheriji, N., Dallali, H., Gouiza, I., Hechmi, M., Mahjoub, F., Mrad, M., Krir, A., Soltani, M., Trabelsi, H., Hamdi, W., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1224284 · Cited by 3
Altan, M., Anık, A., Bayar, N. T. I., Bozkurt, G., Ünüvar, T., & Anık, A. (2020) · Trends in Pediatrics · doi:10.5222/tp.2020.58076 · Cited by 3
Self-citationChildhood-onset mild diabetes caused by a homozygous novel variant in the glucokinase gene
Filibeli, B. E., Çatlı, G., Ayrancı, İ., Manyas, H., Kırbıyık, Ö., & Dündar, B. N. (2021) · HORMONES · doi:10.1007/s42000-021-00330-1 · Cited by 3
Self-citationMaturity Onset Diabetes of the Young: The Indian Scenario
Sarkar, A., & Rajamani, J. I. (2022) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.15.1.2 · Cited by 3
Less common forms of diabetes in young population
Tekielak, A., Otto-Buczkowska, E., & Rusak, E. (2024) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2024.136279 · Cited by 3
Sanrı, A., Çetin, T., Acikgoz, E. G., Mutlu, M. B., & Sezer, Ö. (2025) · Pediatric Diabetes · doi:10.1155/pedi/4035026 · Cited by 3
Иванощук, Д. Е., Шахтшнейдер, Е. В., Ovsyannikova, A. K., Михайлова, С. В., Rymar, O. D., Oblaukhova, V. I., Yurchenko, A. A., & Voevoda, M. I. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.41-o · Cited by 3
Álvarez, M., Rincón, O., Alvarado, A., & Puentes, F. (2022) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0166 · Cited by 3
Maturity-Onset Diabetes of the Young: A Genetic Form of Diabetes in Children
Welsh, K. M. (2016) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2016.11.003 · Cited by 3
Patil, M. S., Mane, P. M., Datkhile, K. D., Garud, A., Kale, S. R., Patil, S. S., & Patil, S. R. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i4s.4785 · Cited by 3
Ramzy, A., Edeer, N., Baker, R. K., O’Dwyer, S. M., Mojibian, M., Verchere, C. B., & Kieffer, T. J. (2022) · Endocrinology · doi:10.1210/endocr/bqac051 · Cited by 3
Diabetes del adulto de inicio juvenil (diabetes tipo MODY)
Bobadilla-Olaje, G. F., Calleja-López, J. R. T., Ruibal-Tavares, E., Rivera-Rosas, C. N., & Aguilera-Duarte, L. J. (2022) · Revista Mexicana de Pediatría · doi:10.35366/106857 · Cited by 3
Maturity Onset Diabetes of the Young: case report
Rangel-Coronado, R., Chávez-García, T., Mendoza‐Zubieta, V., & Ferreira‐Hermosillo, A. (2019) · PubMed · Cited by 3
Maturity Onset Diabetes of the Young (MODY) : Diagnosa dan Tatalaksana
Suwandi, J. F., Angraini, D. I., & Putri, S. D. (2019) · Jurnal Kedokteran Universitas Lampung · doi:10.23960/jkunila.v3i1.pp226-231 · Cited by 3
Maturity Onset Diabetes of the Young (MODY) - An essence
Bisht, R. (2016) · The Journal of Medical Research · doi:10.31254/jmr.2016.2201 · Cited by 3
Muriel, R. A. S. (2022) · Gredos (University of Salamanca) · doi:10.14201/gredos.149564 · Cited by 2
Daggag, H., Gjesing, A. P., Mohammad, A., Ängquist, L. H., Shobi, B., Antony, S., Haj, D., Tikriti, A. A., Buckley, A. J., Hansen, T. F., et al. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100213 · Cited by 2
A case of mody 2 - Associated hyperglycemia diagnosed as gestational diabetes
Chakarova, N. Y., Balabanski, L., Dimova, R. B., Tsarkova, P., & Tankova, T. I. (2022) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2022-0008 · Cited by 2
Variants of the HNF4A and HNF1A genes in patients with impaired glucose metabolism and dyslipidemia
Иванощук, Д. Е., Ovsyannikova, A. K., Михайлова, С. В., Шахтшнейдер, Е. В., Valeev, E., Rymar, O. D., Orlov, P. S., & Voevoda, M. I. (2022) · Ateroscleroz · doi:10.52727/2078-256x-2021-17-4-11-19 · Cited by 2
Hosseini, S. A., Shadmehri, S., Bazkhaneh, Z. R., Rahmani, M., & Kazemi, N. (2019) · Thrita · doi:10.5812/thrita.84879 · Cited by 2
Pérez-López, P., Bahillo-Curieses, P., Fernández-Velasco, P., Martínez, R., Delgado, E., Ortolá, A., de Luis, D. A., & Díaz-Soto, G. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.12.008 · Cited by 2
Guzmán, G. E., Madariaga, I., Vargas-Potes, C. J., Ballen, L. J., Guerra, M. A., & Nastasi-Catanese, J. A. (2023) · Journal of Medical Case Reports · doi:10.1186/s13256-023-03873-6 · Cited by 2
The effect of HNF4α knockout in beta cells is age and sex dependent
Villaca, C. B. P., Oliveira, V. R., dos Santos, G. J., & Ortis, F. (2025) · Islets · doi:10.1080/19382014.2025.2552549 · Cited by 2
Diabetes: a global challenge and the impact of melatonin
Rana, A., & Kushnir, О. Y. (2024) · Natural & Mathematical Sciences in Medicine and Medical Education · doi:10.24061/3083-5887.j.nmsmme.2024.1.i.1 · Cited by 2
Duration-dependent alterations of lipid profiles and microvascular complications in GCK-MODY
Huang, Y., Fan, Y., Liu, Y., Liu, X., Li, W., Yang, Y., Zhang, Z., Ma, S., Ji, S., Chen, S., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168137 · Cited by 2
Diagnosis of MODY - brief overview for clinical practice
Urbanová, J., Brunerová, L., & Brož, J. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.054 · Cited by 2
Maturity Onset Diabetes of the Young and Generalized Stage III Grade C Periodontitis: A Case Report
Chew, R. J. J., & Chee, H. K. (2020) · Clinical Advances in Periodontics · doi:10.1002/cap.10114 · Cited by 2
Pharmacological profile of medicinal plants used to control diabetes
Chaudhary, N., & Tyagi, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95719-9.00014-8 · Cited by 2
Drettas, P., Tatanis, V., Spiliopoulou, C., Adonakis, G. G., & LIATSIKOS, E. N. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000657 · Cited by 2
Zhang, S., Ma, Y., Zang, X., Heng, H., Liu, X., Peng, G., Liu, R., Liang, J., & Geng, H. (2024) · The Application of Clinical Genetics · doi:10.2147/tacg.s465859 · Cited by 2
DETEKSI GEN GLUKOKINASE PADA REMAJA DI PESISIR KOTA KENDARI SULAWESI TENGGARA
Lio, T. M. P., & Sugireng, S. (2019) · BIOMA JURNAL BIOLOGI MAKASSAR · doi:10.20956/bioma.v4i2.7276 · Cited by 2
Kayaş, L., Akıncı, A., Çamtosun, E., Dündar, İ., Çiftçi, N., Esener, Z., Tekedereli, İ., & Doğan, M. (2025) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2025.2024-10-18 · Cited by 2
Diabetes-associated autoantibodies among young diabetes mellitus patients in Malaysia
Mahayidin, H., Zakariah, S. Z., Ishah, N. A., Wee, X. A., Arip, M., & Nor, N. M. (2020) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 2
Diabetes in the Pediatric Age Group: A Case Series and Review of Literature
Valenzuela-Ruiz, J. R., Bobadilla-Olaje, G. F., Calleja-López, J. R. T., Ruibal-Tavares, E., Rivera-Rosas, C. N., Aguilera-Duarte, L. J., & Ruiz-Quiroz, J. O. (2023) · Journal of Pediatrics Review · doi:10.32598/jpr.11.2.1101.1 · Cited by 1
Foster, T., Sharma, R., & Walizai, T. (2018) · Radiopaedia.org · doi:10.53347/rid-64064 · Cited by 1
Hemoglobin A1C can differentiate subjects with GCK mutations among patients suspected to have MODY
Uzman, C. Y., Erbaş, İ. M., Bozkaya, Ö. G., Paketçi, A., Çağlayan, A. O., Abacı, A., Kulali, M. A., Böber, E., Kekilli, A., Çinleti, T., et al. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0381 · Cited by 1
Self-citationHoméostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63 · Cited by 1
Maturity-Onset Diabetes of the Young (MODY)
Giuffrida, F. M. A., & Moisés, R. S. (2026) · Contemporary Endocrinology · doi:10.1007/978-3-032-17036-1_8 · Cited by 1
Protein Networks in Human Disease
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_1 · Cited by 1
Vázquez-Mosquera, M. E., González‐Vioque, E., Gouveia, S., Bellido, D., Pérez, C. T., Olmos, M. Á. M., Fernández‐Pombo, A., Castaño-González, L. A., Chans-Gerpe, R., & Couce, M. L. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02263-3 · Cited by 1
HNF1A-MODY Mutations in Nuclear Localization Signal Impair HNF1A-Import Receptor KPNA6 Interactions
Asaad, F., Korulu, Ş., Özbil, M., & Çapan, Ö. Y. (2021) · The Protein Journal · doi:10.1007/s10930-020-09959-0 · Cited by 1
Berlioz, A. R., Patel, R., Gardner, D., Kurukulasuriya, L. R., & Sowers, J. R. (2021) · American Diabetes Association eBooks · doi:10.2337/9781580407663.case1 · Cited by 1
Slaoui, K., Hami, H., Redouane, S., Charoute, H., Khair, K. E., Soulaymani, A., & Barakat, A. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2593547 · Cited by 1
Berstein, L. M. (2019) · Future Oncology · doi:10.2217/fon-2019-0643 · Cited by 1
HNF1B variant without hyperglycaemia as a cause of isolated profound hypomagnesaemia
Vollmer, S., Katzman, P., & Löndahl, M. (2023) · BMJ Case Reports · doi:10.1136/bcr-2022-254274 · Cited by 1
Genotype-Phenotype Correlation in a MODY 2 Family: An Under-Diagnosed Disease
Fabiano, M. C., Verrienti, A., Carbone, A., Sponziello, M., Bellitti, P., & Bruno, R. (2016) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2016.64027 · Cited by 1
Demystifying Maturity Onset Diabetes of the Young (MODY)
Welsh, K. M. (2016) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2016.03.010 · Cited by 1
Current treatment options in Maturity-Onset Diabetes of the Young
Brunerová, L., Urbanová, J., & Brož, J. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.055 · Cited by 1
Hermayanti, D., & Nursiloningrum, E. (2018) · Saintika Medika · doi:10.22219/sm.v13i1.5443 · Cited by 1
Clinical and molecular characterization of Portuguese patients with a clinical diagnosis of MODY
de Mafra, J. P. D. M. G. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Retinal Imaging Findings in Patients with Maturity-Onset Diabetes of the Young
Lin, M., Shah, J., Alonso, L. C., Kiss, S., & Kovacs, K. D. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100737 · Cited by 1
Mutations in the HNF1A gene as a cause of MODY3: a clinical case
Demidova, T. Y., Gritskevich, Е. Y., & Балутина, О. В. (2019) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2019-47-021 · Cited by 1
Batool, M., Munawar, M. A., Basra, M. A. R., Amanat, S. A. S., Amir, S., & Ahmad, H. A. (2023) · Research Prospects in Natural Sciences (RPNS) · Cited by 1
Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
Smati, S. (2019) · theses.fr (ABES) · doi:10.70675/01997f55za990z41e6z96baz8221de2a6281
Herbal Anti Diabetic A Review Efficacy and Mechanisms
Shinde, K., Waghmare, S., Nikam, N. V., Chavan, S., & Lahare, P. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-23037
O papel do HNF4 na morte das células beta pancreáticas induzida por citocinas pró-inflamatórias.
Stefano, A. G. D. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2020.tde-16072020-154124
Leslie, K. A. (2019) · Figshare
Abstracts from ABCD Conference: 7 - 8 September, 2022, NEC, Birmingham
Two, A. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.393
Heald, A. H., & Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00017-6
Hojanepesov, O. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-7sqk-m590
Caetano, L. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-26032018-131334
Karakılıç, E., Saygılı, E. S., Sılan, F., Öndüç, G. G., & Agcaoglu, U. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-01027-2
Pirimoglu, M. B., Öğütlü, Ö. B. G., Nursoy, H., Önay, H., Sağ, Ş. Ö., Temel, Ş. G., & Eren, E. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04020-4
Doğan, Ç., Andaç, B., Başaran, M. N., Günay, Y., Alay, M. T., & Yiğin, A. K. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12404-7
PHYSICAL THERAPY APPROACHES FOR CHILDREN WITH DIABETES: A REVIEW
(2023) · Egyptian Journal of Applied Science · doi:10.21608/ejas.2023.325261
Cellular Immunological Mechanisms Contributing to Diabetes Pathogenesis
Radenkovic, M. (2016) · Lund University Publications (Lund University)
de Oliveira, C. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-16082019-155417
Hodeib, M., Meabed, M., Abougabal, K. M., & Etman, G. (2021) · The Egyptian Journal of Pediatric Allergy and Immunology · doi:10.21608/ejpa.2021.61225.1020
COVID-19 y diabetes mellitus: Problema de salud pública en México
Rivera-Rosas, C. N., Calleja-López, J. R. T., Tagles, H. D., & Acuña-Hernández, M. A. (2021) · REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · doi:10.59420/remus.6.2021.4
Neonatal and Childhood Consequences of Maternal Obesity and Diabetes
Hulst, A. V., Savard, C., Harnois‐Leblanc, S., Gingras, V., & Henderson, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00016-8
Role of Genes in Diabetes mellitus
Sunder, A. (2025) · Acta Scientific Medical Sciences · doi:10.31080/asms.2024.08.1835
"Double" Diabetes in Members of One Family: Clinical Case and Literature Review
Волкова, Н. В., Солнцева, А. В., Gudynо, V. S., & Пугавко, Т. Б. (2020) · Педиатрия Восточная Европа · doi:10.34883/pi.2020.8.1.009
Il MODY: genetica e quadri clinici associati
Resi, V., & Grancini, V. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01353-z
Barszcz, K. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2023.tde-15022024-155721
Clinical Diagnosis and Manifestations of Specific Conditions
Solomon, B. D. (2022) · Wiley eBooks · doi:10.1002/9781119847212.ch3
Caracterização do modelo animal de camundongos knockout condicional para HNF4α em células β
Villaca, C. B. P. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2022.tde-18082023-140150
Polygenic Risk Score in Clinical Practice: A Review
Tummala, K. (2025) · Indian Journal of Clinical Cardiology · doi:10.1177/26324636251360044
Moodley, N. (2020) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/3998
Metadata
- Authors
- Anık, A., Çatlı, G., Abacı, A., & Böber, E.
- Affiliations
- Dokuz Eylül University (TR)
- Corresponding author
- Abacı, Ayhan
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 28
- Issue
- 3-4
- Pages
- 251-63
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W1986614590
- Cited by
- 198
- References
- 118
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 36 · 2021: 28 · 2020: 29 · 2019: 25 · 2018: 17 · 2017: 8 · 2016: 7 · 2015: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- maturity-onset diabetes of the young, monogenic diabetes, HNF1A mutations, HNF4A mutations, HNF1B mutations, beta-cell dysfunction, pancreatic agenesis, sulfonylurea therapy, ATP-sensitive potassium channels, molecular diagnosis, fasting hyperglycemia, microvascular complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Glucokinase, Humans, Mutation, Sulfonylurea Compounds, Prevalence, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.